Connect your AI

MeiraGTx Holdings plc MGTX Total Equity

Total Equity at other companies

Regeneron PharmaceuticalsREGN

$31.42B+6.9%

Opko HealthOPK

$1.2B-8.2%

Relay Therapeutics, Inc.RLAY

$642.18M-10.9%

Zevra Therapeutics, Inc.ZVRA

$205.8M+402%

ALN

Alnylam PharmaceuticalsALNY

$1.08B+152%

Intellia TherapeuticsNTLA

$620.94M-20.4%

Other financials

Income statement

Revenue$293.0K-84.8%

Operating income-$40.8M+1.9%

Net income-$46.3M-15.8%

EPS (diluted)-$0.57-11.8%

Balance sheet

Cash & equivalents$71.5M+7.5%

Total debt$62.7M-22.5%

Total assets$244.7M+9.2%

Cash flow

Operating cash flow$17.8M+148%

CapEx$2.0M+17.4%

Free cash flow$15.8M+141%

Valuation

Market cap$1.07B+111%

Enterprise value$1.07B+103%

P/S13.5×-1.3×

Profitability

Operating margin-597.9%-207pp

Net margin-615.3%—

FCF margin-441.5%-126pp

Returns & leverage

Return on equity-379.5%—

Debt / equity27.2×+26.1×

Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is MeiraGTx Holdings plc's total equity?: MeiraGTx Holdings plc (MGTX) reported total equity of -$58.13M in Q1 2026.
How has MeiraGTx Holdings plc's total equity changed year-over-year?: MeiraGTx Holdings plc's total equity decreased by 275.6% year-over-year, from $33.1M to -$58.13M.
What is the long-term trend for MeiraGTx Holdings plc's total equity?: Over 5 years (2020 to 2025), MeiraGTx Holdings plc's total equity has grown at a -52.5% compound annual growth rate (CAGR), from $238.56M to -$5.79M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.